Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNIVUS-DAPT: 1-Month DAPT After IVUS-Guided Synergy Stent
NCT03606642Phase 2Terminated
- Sponsor
- HonorHealth Research Institute
- Start
- Nov 2018
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, clopidogrel, prasugrel, ticagrelor in coronary artery disease (CAD), atherosclerosis, sponsored by HonorHealth Research Institute. Started Nov 2018; status: terminated.
02
Drugs
aspirinclopidogrelprasugrelticagrelor
03
Conditions
coronary artery disease (CAD)atherosclerosis
Beyond the preview
Go deeper on NCT03606642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606642.